Immobilized Monoclonal Anti-Influenza HA Universal Antibody, Human IgG1 at 2 μg/mL (100 μL/well) can bind Biotinylated Influenza A [A/Guinea fowl/Hong Kong/WF10/99(H9N2)] HA, Avitag,His Tag (Cat. No. HA2-V82E3) with a linear range of 10-156 ng/mL (QC tested).
The purity of Influenza A [A/Guinea fowl/Hong Kong/WF10/99(H9N2)] HA, His Tag (Cat. No. HA2-V52H4) is more than 90% and the molecular weight of this protein is around 70-90 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Anti-influenza monoclonal antibody (AIMM Therapeutics) | Phase 1 Clinical | Aimm Therapeutics | Influenza, Human | Details | |
Influenza vaccine quadrivalent (Nitto/Osaka) | NSV-0001 | Osaka University, Nitto Denko | Details | ||
Gedivumab | RG-7745; MHAA-4549A | Genentech Inc | Details |
This web search service is supported by Google Inc.